Acta Neurologica Scandinavica

Papers
(The TQCC of Acta Neurologica Scandinavica is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Neurological Manifestations of COVID‐19: A systematic review and current update281
Neurological side effects of SARS‐CoV‐2 vaccinations101
The potential neurological effect of the COVID‐19 vaccines: A review81
Epilepsy in time of COVID‐19: A survey‐based study70
Effect of COVID‐19 pandemic on stroke admission rates in a Norwegian population56
The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use52
Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis45
Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials34
Glymphatic dysfunction in isolated REM sleep behavior disorder34
Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis34
Parkinson’s disease and intensive exercise therapy — An updated systematic review and meta‐analysis33
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis33
In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches30
Blood biomarkers for Alzheimer's disease and related disorders30
COVID‐19 presentations and outcome in patients with epilepsy30
Blood biomarkers in ALS : challenges, applications and novel frontiers27
Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review27
Refractory migraine profile in CGRP‐monoclonal antibodies scenario27
Neurophysiological impairments in multiple sclerosis—Central and peripheral motor pathways26
Air pollution, a possible risk factor for multiple sclerosis25
Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe24
Medication adherence/persistence among patients with active multiple sclerosis in Finland24
SARS‐CoV‐2 vaccines are not free of neurological side effects24
Prevalence of non‐motor symptoms and their association with quality of life in cervical dystonia22
Systolic blood pressure variability following endovascular thrombectomy and clinical outcome in acute ischemic stroke: A meta‐analysis22
Multiple cranial nerve palsies following COVID‐19 vaccination—Case report21
Vagus nerve stimulation in patients with Lennox‐Gastaut syndrome: A meta‐analysis21
Generalized status epilepticus as a possible manifestation of COVID‐1921
Microglia and immunotherapy in Alzheimer’s disease21
A meta‐analysis of collateral status and outcomes of mechanical thrombectomy20
Military service and related risk factors for amyotrophic lateral sclerosis20
Impacts of the COVID‐19 pandemic on Iranian patients with epilepsy19
Multiple sclerosis and COVID‐19: The Swedish experience19
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials19
Guillain‐Barre syndrome following COVID‐19 vaccines: A scoping review19
Neurological manifestations as primary presentation of COVID‐19 in hospitalized patients18
Effectiveness of clinical exome sequencing in adult patients with difficult‐to‐diagnose neurological disorders18
Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis17
Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID‐19 pandemic17
Potassium channels and epilepsy17
Non‐motor symptoms in patients with autosomal dominant spinocerebellar ataxia17
Non‐pharmacological therapies for pain management in Parkinson's disease: A systematic review17
People with epilepsy still feel stigmatized16
Accuracy of NIH Stroke Scale for diagnosing aphasia16
Evidence‐based anti‐seizure monotherapy in newly diagnosed epilepsy: A new approach16
Risk factors for minor hallucinations in Parkinson's disease16
Myasthenia gravis and COVID‐19: A case series and comparison with literature16
Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report15
A nomogram to predict mechanical ventilation in Guillain‐Barré syndrome patients15
Identifying epilepsy psychiatric comorbidities with machine learning15
Blood biomarkers of peripheral neuropathy15
Prevalence and risk of thyroid diseases in myasthenia gravis14
CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis14
Supervised exercises versus telerehabilitation. Benefits for persons with multiple sclerosis14
Epilepsy and lockdown: A survey of patients normally attending a Spanish centre14
Socioeconomic consequences of multiple sclerosis—A systematic literature review14
Blood biomarkers in epilepsy14
Mechanical thrombectomy with or without thrombolysis: A meta‐analysis of RCTs14
Heart rate variability in frontal lobe epilepsy: Association with SUDEP risk14
Clinical features and outcomes of benign recurrent vertigo: A longitudinal study13
Parkinson’s disease in Sweden—resource use and costs by severity13
Myositis‐specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies13
Neurological symptoms and blood neurofilament light levels13
DNA methylation of the 5′‐UTR DAT 1 gene in Parkinson's disease patients13
Machine learning analysis of heart rate variability to detect delayed cerebral ischemia in subarachnoid hemorrhage13
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis13
Eslicarbazepine acetate in post‐stroke epilepsy: Clinical practice evidence from Euro‐Esli12
In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis12
Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review12
Myelin‐associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease12
Aquatic therapy in stroke rehabilitation: systematic review and meta‐analysis12
Quality of life long after temporal lobe epilepsy surgery12
Long‐term prognosis related to deep sedation in refractory status Epilepticus12
Outcomes in three cases after brivaracetam treatment during pregnancy12
Comorbidities in older patients with myasthenia gravis — Comparison between early‐ and late‐onset disease12
Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis12
Association between inflammatory response and outcome after subarachnoid haemorrhage12
Quality of life in patients with glioblastoma and their relatives12
Neurofunctional outcomes in patients with anti‐leucine‐rich glioma inactivated 1 encephalitis11
Brain networks in migraine with and without aura: An exploratory arterial spin labeling MRI study11
Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis11
Efficacy of high‐intensity aerobic exercise on common multiple sclerosis symptoms11
Upregulated serum miR‐128‐3p in progressive and relapse‐free multiple sclerosis patients11
Gamma knife surgery in the treatment of intracanalicular vestibular schwannomas11
Changes in multiple sclerosis epidemiology in Finland over five decades11
Therapy delay in status epilepticus extends its duration and worsens its prognosis11
Seizure freedom as an outcome in epilepsy treatment clinical trials11
Early identification of epilepsy surgery candidates: A multicenter, machine learning study11
Advances in sudden unexpected death in epilepsy11
Fatigue 7 years post‐stroke: Predictors and correlated features11
Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial11
Neuromodulation in drug‐resistant epilepsy: A review of current knowledge11
Meta‐analysis of melatonin levels in cluster headache—Review of clinical implications11
Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis11
Small fiber neuropathy11
Impact of comorbidities on the disability progression in multiple sclerosis10
Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients10
Pregnancy and neurologic complications of COVID‐19: A scoping review10
Functional outcome and quality of life after meningioma surgery: a systematic review10
Progressive external ophthalmoplegia associated with novel MT ‐ TN mutations10
Ischemic stroke patients with prestroke dependency: Characteristics and long‐term prognosis10
Ketamine in adult super‐refractory status epilepticus: Efficacy analysis on a prospective registry10
Intravenous sodium valproate for acute migraine in the emergency department: A meta‐analysis10
Meta‐analysis of association between migraine and risk of dementia10
Blood based biomarkers for movement disorders10
Plasma total tau predicts executive dysfunction in Parkinson's disease10
Physical activity and cognition in young‐onset Parkinson’s disease10
Temporal lobe epilepsy with amygdala enlargement: A systematic review10
Neuropsychological screening in the acute phase of cerebrovascular diseases9
Diversified social cognition in temporal lobe epilepsy9
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke9
Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease9
Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia9
Effects of transdermal nicotine delivery on cognitive outcomes: A meta‐analysis9
Time course of 75%–100% efficacy response of adjunctive brivaracetam9
Dynamic gray matter and intrinsic activity changes after epilepsy surgery9
Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis9
Potential role of brivaracetam in pediatric epilepsy9
Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate9
Treatment satisfaction with calcitonin gene‐related peptide monoclonal antibodies as a new patient‐reported outcome measure: A real‐life experience in migraine9
Critical illness polyneuromyopathy: Functional impact after severe acquired brain injuries9
Clinical outcomes and safety profile of Tenecteplase in wake‐up stroke9
Verbal and spatial memory spans in mild cognitive impairment9
Electrodiagnostic findings in patients with non‐COVID‐19‐ and COVID‐19‐related acute respiratory distress syndrome9
Birth characteristics and risk of febrile seizures9
Severe neurological nicotine intoxication by e‐cigarette liquids: Systematic literature review8
Seizure freedom and plasma levels of newer generation antiseizure medications8
Optical coherence tomography in patients with Wilson's disease8
Medical complications and outcome after endovascular therapy for acute ischemic stroke8
Medium‐term effects of COVID‐19 pandemic on epilepsy: A follow‐up study8
Basal IL‐6 and S100b levels are associated with infarct volume8
Prevalence and development of idiopathic normal pressure hydrocephalus: A 16‐year longitudinal study in Japan8
Association of consciousness impairment and mortality in people with COVID‐198
Bone health, intellectual disability and epilepsy: An observational community‐based study8
Is wearing a face mask safe for people with epilepsy?8
Initial cognitive impairment predicts shorter survival of patients with glioblastoma8
Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy‐related inflammation8
Swedish guidelines for device‐aided therapies in Parkinson's disease —Economic evaluation and implementation8
Brain networks in patients with isolated or recurrent transient global amnesia8
European perspective of perampanel response in people with Intellectual Disability8
Associations between seizures and MRI in patients with anti‐NMDAR encephalitis8
Incidence and mortality in adults with epilepsy in northern Spain8
Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy8
Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta‐analysis8
0.065969944000244